Esto se sabe sobre Opill, la nueva ‘minipíldora’ anticonceptiva
Los asesores de la FDA afirman que los beneficios superan [...]
Los asesores de la FDA afirman que los beneficios superan [...]
F.D.A. advisers voted that the benefits of a nonprescription pill [...]
The panel will vote Wednesday on whether the risks outweigh [...]
The first U.S. application for sale of a nonprescription birth [...]
Two drugmakers have been mired for years in the pre-application [...]